About MeI am a medical oncologist specializing in genitourinary cancers and have more than three decades of experience focusing on prostate cancer and other urogenital cancers. Our multidisciplinary approach offers recently diagnosed patients a thorough assessment of their therapy options. Based on the unique aspects of your situation, we create a personalized treatment plan for your journey from cancer patient to cancer survivor. I was rated in the top 10 percent of physicians in the nation for patient satisfaction in 2016 and 2017.
We provide expertise in prevention, diagnosis, active surveillance, and treatment of advanced disease. New research trials available for prostate cancer include hormonal agents, immunology, radiation therapy, chemotherapy, and lifestyle/dietary changes.
At the James we’re very fortunate to have a National Cancer Institute-designated Comprehensive Cancer Center on the same campus as a remarkable research facility. This is a place where the translation of basic science to clinical care is seamless and continually evolving.
- Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2016, 2017
- Named to the Castle Connolly list of America’s “Top Doctors” for 2017
- Best Doctor in America 2017
Specialties and conditions I treat
- Medical Oncology
- Prostate Cancers
- Bladder Cancer
- Testicular Cancers
- Kidney Cancers
- Urogenital Cancers
Locations where I practice
Education and training
University of Illinois College of Medicine
More about my work
Dana-Farber Cancer Institute
7/1/1988 - 6/30/1991
American Board of Internal Medicine
American Board of Internal Medicine (Subspecialty: Medicine Oncology)
News about me
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/28/2017, Dr. Clinton has reported no financial relationships with medical device, research and/or drug companies.